The capital structure has shifted significantly, with total debt reaching $2.1 billion and the debt-to-equity ratio climbing to 4.68 as of 2026Q1.
| Total Current Assets | 404.21M | 383.1M | 437.21M | 294.42M | 284.63M |
| Cash & Short-Term Investments | 61.7M | 79.9M | 183.25M | 31.37M | 37.66M |
| Cash Only | 61.7M | 79.9M | 183.25M | 31.37M | 37.66M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 296.51M | 257.9M | 217.72M | 216.19M | 206.26M |
| Days Sales Outstanding | 45.18 | 43.51 | 41.82 | 42.93 | 43.66 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 18.33M | 45.3M | 34.69M | 38.87M | 34.03M |
| Total Non-Current Assets | 2.49B | 2.66B | 2.08B | 2.19B | 2.01B |
| Property, Plant & Equipment | 724.54M | 708.96M | 633.52M | 576.22M | 533.93M |
| Fixed Asset Turnover | 3.15x | 3.05x | 3.00x | 3.19x | 3.23x |
| Goodwill | 1.48B | 1.48B | 1.23B | 1.23B | 1.23B |
| Intangible Assets | 238.95M | 242.56M | 204.72M | 224.77M | 247.57M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 20.43M | 200.23M | 11M | 8.41M | 5.24M |
| Total Assets | 2.89B | 3.04B | 2.52B | 2.49B | 2.3B |
| Asset Turnover | 0.77x | 0.71x | 0.75x | 0.74x | 0.75x |
| Asset Growth % | 53.32% | 20.51% | 1.34% | 8.29% | - |
| Total Current Liabilities | 320.88M | 337.25M | 307.19M | 274.63M | 279.63M |
| Accounts Payable | 31.74M | 21M | 19.75M | 20.41M | 27.67M |
| Days Payables Outstanding | 7.04 | 4.95 | 5.25 | 5.62 | 7.67 |
| Short-Term Debt | 98.92M | 95.32M | 10.09M | 74.4M | 1.67M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 53K |
| Other Current Liabilities | 74.49M | 220.09M | 43.65M | 75.11M | 73.19M |
| Current Ratio | 1.26x | 1.14x | 1.42x | 1.07x | 1.02x |
| Quick Ratio | 1.26x | 1.14x | 1.42x | 1.07x | 1.02x |
| Cash Conversion Cycle | 38.13 | - | - | - | - |
| Total Non-Current Liabilities | 2.11B | 2.28B | 1.92B | 1.04B | 1.02B |
| Long-Term Debt | 1.56B | 1.56B | 1.47B | 473.29M | 633.91M |
| Capital Lease Obligations | 1.78B | 445.27M | 399.88M | 357.31M | 332.77M |
| Deferred Tax Liabilities | 337.78M | 228.68M | 25.38M | 177.57M | 29.8M |
| Other Non-Current Liabilities | 43.46M | 44.51M | 24.04M | 27.52M | 25.02M |
| Total Liabilities | 2.44B | 2.62B | 2.22B | 1.31B | 1.3B |
| Total Debt | 2.12B | 2.1B | 1.95B | 905M | 1.04B |
| Net Debt | 2.06B | 2.02B | 1.77B | 873.63M | 1B |
| Debt / Equity | 4.68x | 5.00x | 6.53x | 0.77x | 1.04x |
| Debt / EBITDA | 0.97x | 0.97x | 5.25x | 2.51x | 3.13x |
| Net Debt / EBITDA | 0.94x | 0.93x | 4.75x | 2.42x | 3.02x |
| Interest Coverage | 3.19x | 3.05x | 4.32x | 2.52x | 8.11x |
| Total Equity | 453.97M | 420.43M | 298.72M | 1.18B | 996.12M |
| Equity Growth % | 42.94% | 40.74% | -74.63% | 18.2% | - |
| Book Value per Share | 3.54 | 3.28 | 2.33 | 9.30 | 7.87 |
| Total Shareholders' Equity | 424.71M | 393.28M | 275.67M | 1.16B | 973.32M |
| Common Stock | 1.28M | 1.29M | 1.28M | 470.3M | 464.73M |
| Retained Earnings | 186.84M | 146.45M | 13.55M | 685.29M | 508.59M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.31M | -3.35M | 0 | 0 | 0 |
| Minority Interest | 29.26M | 27.15M | 23.05M | 21.84M | 22.8M |
High leverage and goodwill
As reported in recent financial statements, Concentra's debt-to-equity ratio has surged from 0.68 in 2024Q2 to 4.68 by 2026Q1, signaling a rapid shift toward a more leveraged capital structure that warrants close monitoring by investors concerned with long-term balance sheet stability.
The dramatic increase in leverage following the separation from Select Medical suggests that the company has taken on significant debt to fund its standalone operations or capital structure optimization. This trajectory indicates a transition from a parent-subsidized entity to a highly leveraged independent firm, which may limit future financial flexibility.
Based on the company's reported figures, total debt has ballooned to $2.1 billion as of 2026Q1, representing a substantial portion of the balance sheet and pushing the debt-to-equity ratio to 4.68, which appears to be a significant departure from the company's historical leverage profile.
The concentration of debt relative to equity suggests that the company's ability to absorb operational shocks is diminished compared to its pre-IPO state. Investors should consider whether this debt load is sustainable given the inherent volatility in clinical labor costs and the potential for cyclical downturns in the industrial sectors served.
According to recent SEC filings, goodwill accounts for approximately $1.5 billion of the $2.9 billion total asset base, indicating that a significant portion of the company's valuation is tied to intangible assets rather than tangible clinical infrastructure or physical property.
The heavy reliance on goodwill suggests that past acquisitions are the primary drivers of the current asset base, which introduces the risk of future impairment charges if the acquired clinics fail to meet performance expectations. This asset mix highlights the importance of monitoring the underlying profitability of the clinic network.
As indicated by the provided data, the current ratio has fluctuated between 1.10 and 1.26 over the last five quarters, suggesting that the company maintains a relatively thin liquidity buffer to cover its short-term obligations in a capital-intensive healthcare environment.
The narrow current ratio implies that the company has limited room for error regarding working capital management, particularly given the volatility in receivables noted in prior cash flow analysis. This liquidity profile suggests that any disruption in cash collection cycles could necessitate external financing or further strain the balance sheet.
Quick answers to the most common questions about buying CON stock.
As of 2025, Concentra Group Holdings Parent, Inc. (CON) had total assets of $3.04B including $383.1M in current assets.
Concentra Group Holdings Parent, Inc. (CON) carries total debt of $2.10B, offset by $79.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Concentra Group Holdings Parent, Inc. (CON) has total shareholders' equity (book value) of $393.3M ($3.28 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Concentra Group Holdings Parent, Inc. (CON) reported a current ratio of 1.14x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.